
Publications
Scientific articles and outputs from PGNM teams and collaborators.
About
PGNM publications reflect the scientific output of the laboratory’s teams and collaborators, spanning fundamental mechanisms, disease models, technologies and translational research.
2024
The HUSH epigenetic repressor complex silences PML nuclear body- associated HSV-1 quiescent genomes,
Proc Natl Acad Sci U S A 2024 Dec; 121(49): e2412258121.
2024
[Myonuclear domain settings by microtubules and MACF1].
Contrôles des paramètres des domaines nucléaires par les microtubules et la protéine MACF1,
Médecine/Sciences.
2024
Epidermal maintenance of Langerhans cells relies on autophagy-regulated lipid metabolism,
Journal of Cell Biology.
2024
Synthetic injectable and porous hydrogels for the formation of skeletal muscle fibers: Novel perspectives for the acellular repair of substantial volumetric muscle loss,
Journal of Tissue Engineering and Regenerative Medicine.
2024
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice,
Nature Communications.
2024
Different Founding Effects Underlie Dominant Blue Eyes (DBE) in the Domestic Cat,
Animals.
2024
A PAX3 insertion in the Celestial breed and certain feline breeding lines with dominant blue eyes,
Animal Genetics.
2024
H2A.Z is involved in premature aging and DSB repair initiation in muscle fibers,
Nucleic Acids Res 2024 Apr; 52(6): 3031-3049.
2024
The AMPK-related kinase NUAK1 controls cortical axons branching by locally modulating mitochondrial metabolic functions,
Nature Communications.
2024
miR-218-5p and doxorubicin combination enhances anticancer activity in breast cancer cells through Parkin-dependent mitophagy inhibition,
Cell Death Discovery.
2024
Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?,
Cells.
2024
Decline of DNA damage response along with myogenic differentiation,
Life Sci Alliance 2024 Feb; 7(2): .
2024
Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia,
Trends in Molecular Medicine.
2024
Impaired skeletal muscle regeneration in diabetes: From cellular and molecular mechanisms to novel treatments,
Cell Metabolism.
2024
Combining doxorubicin and miR-218-5p: a new strategy to fight breast cancer?,
Autophagy Reports.
2024
A multiple animal and cellular models approach to study frataxin deficiency in Friedreich Ataxia,
Biochim Biophys Acta Mol Cell Res 2024 Oct; 1871(7): 119809.